Predictors of symptomatic lymphocele after kidney transplantation

ConclusionWe found multiple heterogeneous predictors for SL with a common denominator related to surgical management of the retroperitoneal space, peritoneum and the ureter. Future prospective studies are necessary to evaluate the influence of these variables on the development of SL.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research

Related Links:

CONCLUSIONS: While none of described methods enables the simultaneous measurement of all microcirculatory parameters, certain techniques are widely used in arterial hypertension research, while others gain popularity in screening. PMID: 32969283 [PubMed - as supplied by publisher]
Source: Blood Pressure - Category: Hematology Tags: Blood Press Source Type: research
Authors: Podda GM, Fiorelli EM, Birocchi S, Rambaldi B, Di Chio MC, Casazza G, Cattaneo M Abstract Immune thrombocytopenia (ITP) can be associated with lymphoproliferative diseases (LPD) or solid tumors. A systematic review of published literature was conducted to evaluate response to treatment of ITP secondary to malignancy. Primary outcome was overall response (complete response+response) to first-line treatments [steroids alone or in combination with intravenous immunoglobulins (IVIg)]. Among secondary outcomes, overall response to second-line treatments [splenectomy, rituximab or thrombopoietin receptor agonist...
Source: Platelets - Category: Hematology Tags: Platelets Source Type: research
Conclusions and Relevance: Lacking strong evidence indicating significant patient risk for vaginal laser treatment of GSM, the FDA safety communication appears unsubstantiated and implies gender bias. Identified complications suggest most reported “adverse events” represent lack of treatment effect. The well-documented benefits and low risk of adverse event suggest laser therapy for GSM is reasonable with appropriate pretreatment counseling. Additional randomized, well-controlled clinical trials are needed to further elucidate both the safety and efficacy of this nonhormone therapy.
Source: Menopause - Category: OBGYN Tags: Review Articles Source Type: research
Publication date: 26 September–2 October 2020Source: The Lancet, Volume 396, Issue 10255Author(s): Andrew W Horne, Katy Vincent, Catherine A Hewitt, Lee J Middleton, Magda Koscielniak, Wojciech Szubert, Ann M Doust, Jane P Daniels, Suraiya Abdi, Santanu Acharya, Shamma Al-Inizi, Elizabeth Ball, Andrew Baranowski, Nadia Bhal, Kalsang Bhatia, Siladitya Bhattacharya, Judy V. Birch, Tyrone Carpenter, Tony Chalhoub, Ying C. Cheong
Source: The Lancet - Category: General Medicine Source Type: research
Publication date: 26 September–2 October 2020Source: The Lancet, Volume 396, Issue 10255Author(s): Hasan Tahsin Özpolat, Bulent Baran, Filiz Akyuz
Source: The Lancet - Category: General Medicine Source Type: research
Publication date: Available online 24 September 2020Source: Journal of Acupuncture and Meridian StudiesAuthor(s): Abedini Maryam, Aminzadeh Fariba, Manshoori Azita, Bakhtar Babak, Sadeghi Tabandeh
Source: Journal of Acupuncture and Meridian Studies - Category: Complementary Medicine Source Type: research
Publication date: Available online 24 September 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): T.C. Silva, P.O. Silva, D.S. Morais, C.Z. Oppermann, G.B. Penna, A. Paz, B. Ziegler
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research
Authors: Montefusco V, Mussetti A, Sala MR, Martinelli G, Cerchione C Abstract Proteasome inhibitors (PIs) represent a recently developed drug class that inhibit the ubiquitinproteasome system, thus interfering with the intracellular machinery who has the duty of misfolded proteins disposal. Myeloma plasma cells are structurally aimed at the production of large quantities of immunoglobulins. This explains their vulnerability to any perturbation of intracellular protein homeostasis. Bortezomib is the first-in-class PI and nowadays, in combination with other compounds, is the cornerstone of multiple myeloma (MM) trea...
Source: Panminerva Medica - Category: General Medicine Tags: Panminerva Med Source Type: research
Publication date: Available online 24 September 2020Source: Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)Author(s): C. Oliveira, F.P.M. Oliveira, M.J. Barata, S.M. Teixeira, C. João, D.C. Costa
Source: Revista Espanola de Medicina Nuclear e Imagen Molecular - Category: Nuclear Medicine Source Type: research
4 In. Flat Responder Emergency Trauma Dressing part number 30-0171, packaged in kits labeled as follows: a) M-FAK Mini First Aid Kit; Kit Product Code: 80-0890 b) M-FAK Mini First Aid Kit, with Bleeding Control Dressing; Kit Product Code: 80-0891 c) M-FAK Mini First Aid Kit, Advance; Kit Product Code: 80-0892 d) M-FAK Mini First Aid Kit, Basic; Kit Product Code: 80-0913 e) M-FAK Mini First Aid Kit; Kit Product Code: 80-0914 f) Trauma and First Aid Kit; Kit Product Code: 80-0947 g) Trauma and First Aid Kit; Kit Product Code: 80-0948 h) Trauma and First Aid Kit; Kit Product Code: 80-1047 i) Trauma and First Aid Kit Hard Case...
Source: Medical Device Recalls - Category: Medical Devices Source Type: alerts
More News: Bleeding | Kidney Transplant | Kidney Transplantation | Nephrectomy | Pain | Pain Management | Perfusion | Study | Transplant Surgery | Transplants | Ureter and Renal Pelvis Cancer | Urology & Nephrology